D-1041-2018 Class III Terminated

Recalled by Valeant Pharmaceuticals North America LLC — Bridgewater, NJ

FDA drug recall D-1041-2018 was initiated by Valeant Pharmaceuticals North America LLC on Jul 10, 2018 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton. The recall status is terminated (terminated Feb 5, 2019). Affected quantity: 306 cartons.

Recall details

Product Type
Drugs
Report Date
Aug 15, 2018
Initiation Date
Jul 10, 2018
Termination Date
Feb 5, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
306 cartons

Product description

Diazepam Rectal Gel, 2.5 mg, TWIN PACK that Contains two pre-filled, unit-dose, rectal delivery systems with lubricating jelly and instructions for use per carton, Rx only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807; Manufactured by: DPT Laboratories, Ltd., San Antonio, TX 78215; NDC 68682-650-20.

Reason for recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton.

Distribution pattern

Nationwide in the USA

Code information

Lot #: NBBN, Exp 02/22

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1041-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1041-2018. Report a data issue: hello@regdatalab.com.